The Forsyth Institute Joins the Boston Biomedical Innovation Center To Further Healthcare Research and Commercialization of Medical Technologies

BOSTON, JUNE 16, 2015 – The Boston Biomedical Innovation Center (B-BIC), a healthcare consortium designed to accelerate commercialization of biomedical technologies, and the Forsyth Institute, a not-for-profit organization pioneering biomedical research for new diagnostics, devices and therapies, today announce that Forsyth will join B-BIC as a Participating Member. In this capacity, Forsyth researchers will have access to all capability and resources offered by B-BIC – grant funding, coaching, project management support, skill development, and access to FDA, CMS, and the investment community.

“We are very pleased to welcome the Forsyth Institute as a member of B-BIC because its members bring valuable, additional research capabilities to the Center”, said Joseph Loscalzo, MD, PhD, Chair, Department of Medicine at Brigham and Women’s Hospital, and Program Director of B-BIC. “As the newest member of our community, their participation increases B-BIC’s pipeline of clinically-motivated healthcare innovations and expands the range of potential applications”.

“Forsyth and B-BIC share the common goal of translating novel healthcare technologies into clinical practice, and we are, thus, very happy to join the B-BIC community”, said Philip Stashenko, DMD, PhD, President and CEO of Forsyth. “The synergies between our two organizations will strengthen our collective ability to introduce innovations that improve health and patient care.”

Over the next weeks, Forsyth and existing B-BIC investigators will actively identify specific areas of collaboration, share best practices, and participate in skills development activities.

About B-BIC

The Boston Biomedical Innovation Center (B-BIC) is a consortium of academic medical centers, government, non-profit organizations, industry, and venture capital designed to accelerate translation of early stage biomedical innovations into commercially viable products. As an NIH National Center for Accelerated Innovation (NCAI) supported by the National Heart, Lung and Blood Institute (NHLBI), B-BIC provides grants, mentoring, and skills development to academic investigators for development of devices, diagnostics, and therapeutics addressing heart, lung, blood, and sleep disorders. In addition to NHLBI, B-BIC is supported by the two founding institutions of Partners HealthCare, Brigham and Women’s Hospital and Massachusetts General Hospital, as well as Harvard Medical School. The Center also includes Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Boston Medical Center, Boston University, Draper Laboratory, Northeastern University, and the Veterans Administration Boston Healthcare System. For more information, visit b-bic.org.

About The Forsyth Institute

Founded in 1910, the Forsyth Institute is the only independent, not-for-profit research organization in the United States dedicated to understanding the important connections between oral health and overall wellness. Forsyth scientists are shaping the direction of precision medicine through pioneering biomedical research and its direct application to new diagnostics, devices and therapies. Forsyth combines its expertise in oral and associated systemic diseases, to develop new solutions that alleviate daily health challenges for billions. Forsyth is also committed to treating underserved populations in local communities and on a national and global scale. To learn more about Forsyth, visit www.forsyth.org.